Prof. Tim F. Greten is a world expert in gastrointestinal oncology and tumor immunology. A renowned physician-scientist, Prof. Greten leads a research team that explores the tumor microenvironment in liver cancers such as hepatocellular carcinoma and liver metastases. With extensive experience in the development of new therapies, he was among the first to test immune checkpoint inhibitors in liver cancer. As head of the gastrointestinal medical oncology team of the Center for Cancer Research of the National Cancer Institute (NIH), Bethesda (Maryland, USA), he leads innovative clinical trials, covering the full spectrum of research, from basic tumor immunology to phase I and II trials. Prof. Greten has also been very active in the evaluation of MAIT cells in liver cancer, both in terms of basic and translational research, and his experience will have a big impact on the clinical development of Biomunex’ MAIT engagers.